News | December 07, 2022
Concord Biotech gets SEBI nod for IPO
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
New Lexington, Massachusetts facility to provide customer education and collaboration opportunities
This product is based on Osmotic Controlled Release Oral Delivery System technology
Fredun received one-year contract worth Rs. 65 crores from a Southeast Asian country for Pharma exports
Steve joins Sai Life Sciences from GlaxoSmithKline (GSK) where he was a department head and member of the global chemical development leadership team.
The teams will assist the state health authorities in instituting public health measures and facilitate operationalization of requisite control and containment measures
The proceeds from this fund-raise will be deployed in financing the project requirements of the API business
Strand’s new offering will help people better understand and manage diseases through genomic sequencing
Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning
The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees
Subscribe To Our Newsletter & Stay Updated
